Atlas Trials

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

Clinical trial NCT02363400 · TERMINATED

Trial details

NCT number
NCT02363400
Sponsor
National Health Research Institutes, Taiwan
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2014-12-14
Primary completion
2021-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.